Pfizer Inc. (PFE)

Last Closing Price: 37.60 (2023-05-26)

Company Description

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $100.33B
Net Income (Most Recent Fiscal Year) $31.37B
PE Ratio (Current Year Earnings Estimate) 11.23
PE Ratio (Trailing 12 Months) 6.07
PEG Ratio (Long Term Growth Estimate) 1.25
Price to Sales Ratio (Trailing 12 Months) 2.28
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 2.10
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 4.93
Pre-Tax Margin (Trailing 12 Months) 34.37%
Net Margin (Trailing 12 Months) 31.25%
Return on Equity (Trailing 12 Months) 37.53%
Return on Assets (Trailing 12 Months) 18.08%
Current Ratio (Most Recent Fiscal Quarter) 1.37
Quick Ratio (Most Recent Fiscal Quarter) 1.11
Debt to Common Equity (Most Recent Fiscal Quarter) 0.31
Inventory Turnover (Trailing 12 Months) 3.04
Book Value per Share (Most Recent Fiscal Quarter) $17.09
Earnings per Share (Most Recent Fiscal Quarter) $1.23
Earnings per Share (Most Recent Fiscal Year) $6.58
Diluted Earnings per Share (Trailing 12 Months) $5.08
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers - General
Common Shares Outstanding 5.65B
Free Float 5.64B
Market Capitalization $212.26B
Average Volume (Last 20 Days) 30.38M
Beta (Past 60 Months) 0.63
Percentage Held By Insiders (Latest Annual Proxy Report) 0.05%
Percentage Held By Institutions (Latest 13F Reports) 67.62%
Annual Dividend (Based on Last Quarter) $1.64
Dividend Yield (Based on Last Quarter) 4.36%